Clinical Trials Directory

Trials / Recruiting

RecruitingNCT04462042

Proton Versus Photon Therapy in Anal Squamous Cell Carcinoma

Proton Versus Photon Therapy in Anal Squamous Cell Carcinoma - Swedish Anal Carcinoma Study

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
100 (estimated)
Sponsor
Umeå University · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Dosimetric studies suggest that radiotherapy with protons has a potential to reduce side effects compared to treatment with photons for patients with anal carcinoma (AC). There are so far no studies comparing these treatment techniques in a randomised setting. The aim of this study is to compare side effects following photon therapy versus proton therapy within the framework of a randomised controlled trial.

Detailed description

Anal carcinoma is a disease in which modern therapy is reasonably successful in achieving tumour control/cure. Both acute and late side effects are substantial. Proton radiotherapy is hypothesised to have the potential to decrease the incidence/severity of some acute side effects from certain organs at risk e.g. bone marrow and intraperitoneal bowel. By sparing the dose to these organs it is also possible that late effects might be less evident. Sparing of the bone marrow may lead to fewer septic events and dose reductions of chemotherapy which may, as a consequence, improve tumour control. The primary aim of this study is to find ways to decrease acute side effects primarily to alleviate some discomfort from the patient during and after a usually painful treatment experience. It has also been concluded by others that reduction of acute side effects is a relevant aim and end point for the evaluation of new treatment techniques and both patient reported and physician reported data are assessed

Conditions

Interventions

TypeNameDescription
RADIATIONProton radiotherapyProton radiotherapy
RADIATIONPhoton radiotherapyConventional photon radiotherapy

Timeline

Start date
2021-04-07
Primary completion
2026-04-01
Completion
2031-03-28
First posted
2020-07-08
Last updated
2025-04-03

Locations

4 sites across 1 country: Sweden

Source: ClinicalTrials.gov record NCT04462042. Inclusion in this directory is not an endorsement.